International study of the prevalence and outcomes of infection in intensive care units.

By Jean-Louis Vincent, J. Rello, J. Marshall, Eliézer Silva, A. Anzueto, Claude D Martin, R. Moreno, J. Lipman, C. Gomersall, Y. Sakr and 1 more. Journal of the American Medical Association (JAMA), 2009

2,760 citations recorded by the source corpus.

Subfields: Critical Care and Intensive Care Medicine, Epidemiology, Infectious Diseases

View Paper: https://www.semanticscholar.org/paper/c5135219f19476aa00a1c00c6ac80a50793d479e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Critical Care and Intensive Care Medicine

1. C. Richard
2. Mitchell M. Levy
3. X. Monnet
4. F. Tenover

In Epidemiology

1. A. Rhodes
2. C. Richard
3. Laura Evans
4. M. Cecconi
5. Mitchell M. Levy
6. Djillali Annane
7. B. Spellberg
8. X. Monnet

In Infectious Diseases

1. H. Boucher
2. F. Tenover

Citations in the corpus

• Combating antimicrobial resistance: policy recommendations to save lives. (2011, background): “In a recent survey, approximately half of patients in more than 1,000 intensive care units in 75 countries suffered from an infection, and infected patients had twice the risk of dying in the hospital as uninfected patients [5].”
• Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study (2020, methodology): “However, their day-1 PaO2/FiO2 was calculated by converting O2 flow to estimated FiO2 (see conversion tables in the supplement) [14].”
• Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. (2013, background): “Although this commensal organism normally colonizes mucosal surfaces in an asymptomatic manner, it can become one of the most significant causes of a disabling and lethal infection (Wisplinghoff et al., 2006; Vincent et al., 2009).”
• Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options (2017, background): “Most A. baumannii infections occur in critically ill patients in the intensive care unit (ICU) setting (Fournier and Richet, 2006) and account for up to 20% of infections in ICUs worldwide (Vincent et al., 2009).”
• Sepsis and septic shock. (2018, background): “20,24 The 2012 Intensive Care Over Nations study, however, showed that Gram-negative bacterial infect ions were more common than Gram-positive bacterial infections in the USA.”